Media Top News In The News Media Resources TOP NEWS July 20, 2026Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload July 09, 2026Biohaven Announces Scientific Leadership Transitions June 30, 2026Biohaven Completes Enrollment in RISE 3 Pivotal Focal Epilepsy Study with Opakalim, a Selective Kv7.2/7.3 Activator VIEW ALL WE ARE SOCIAL
